Skip to main content
SpringerLink
Log in

Kolorektales Karzinom

  • Chapter
Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen

Part of the book series: Molekulare Medizin ((MOLMED))

  • 56 Accesses

Zusammenfassung

Kolorektale Karzinome (KRK) sind die häufigsten bösartigen Tumoren des Gastrointestinaltrakts und die zweithäufigste zum Tod führende Tumorerkrankung in Deutschland. In Deutschland verstarben 1997 29774 Patienten an den Folgen eines kolorektalen Karzinoms. Jährlich treten in Deutschland <55 000 Neuerkrankungen auf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aaltonen LA, Peltomäki P, Mecklin JP et al. (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54:1645–1648

    PubMed  CAS  Google Scholar 

  • Ahnen DJ, Feigl P, Quan G et al. (1998) Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res 58:1149–1158

    PubMed  CAS  Google Scholar 

  • Andreyev HJ, Norman AR, Cunningham D, Oates JR, Clarke PA (1998) Kirsten ras mutations in patients with colorectal cancer: the multicenter “RASCAL” study. J Natl Cancer Inst 90:675–684

    PubMed  CAS  Google Scholar 

  • Askling J, Dickman PW, Karlen P et al. (2001) Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: a population-based cohort study. Lancet 357:262–266

    PubMed  CAS  Google Scholar 

  • Behrens J, Jerchow BA, Würtele M et al. (1998) Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 280:596–599

    PubMed  CAS  Google Scholar 

  • Benhattar J, Losi L, Chaubert P, Givel JC, Costa J (1993) Prognostic significance of K-ras mutations in colorectal carcinoma. Gastroenterology 104:1044–1048

    PubMed  CAS  Google Scholar 

  • Bodmer WF.., Bailey CJ, Bodmer J et al. (1987) Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 328:614–616

    PubMed  CAS  Google Scholar 

  • Boland CR, Sato J, Appelman H.D., Bresalier RS, Feinberg AP (1995) Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene lod during colorectal cancer progression. Nat Med 1:902–909

    PubMed  CAS  Google Scholar 

  • Bomme L, Bardi G, Pan dis N, Fenger C, Kronborg O, Heim S (1998) Cytogenetic analysis of colorectal adenomas: karyotypic comparisons of synchronous tumors. Cancer enet Cytogenet 106:66–71

    CAS  Google Scholar 

  • Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49:4682–4689

    PubMed  CAS  Google Scholar 

  • Bouzourene H, Gervaz P, Cerottini JP et al. (2000) p53 and Ki-ras as prognostic factors for Dukes’ stage B colorectal cancer. Eur J Cancer 36:1008–1015

    PubMed  CAS  Google Scholar 

  • Brockman JA, Gupta RA, DuBois RN (1998) Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology 115:1049–1055

    PubMed  CAS  Google Scholar 

  • Buglioni S, D’Agnano I, Cosimelli M et al. (1999) Evaluation of multiple bio-pathological factors in colorectal adenocardnomas:independent prognostic role of p53 and bcl-2. Int J Cancer 84:545–552

    PubMed  CAS  Google Scholar 

  • Burt RW (2000) Colon cancer screening. Gastroenterology 119:837–853

    PubMed  CAS  Google Scholar 

  • Cahill DP, Lengauer C, Yu J et al. (1998) Mutations of mitotic checkpoint genes in human cancers. Nature 392:300–303

    PubMed  CAS  Google Scholar 

  • Carethers JM, Hawn MT, Greenson JK, Hitchcock CL, Boland CR (1998) Prognostic significance of allelic lost at chromosome 18q21 for stage 11 colorectal cancer. Gastroenterology 114:1188–1195

    PubMed  CAS  Google Scholar 

  • Cerottini JP, Caplin S, Saraga E, Givel JC, Benhattar J (1998) The type of K-ras mutation determines pro gnosis in colorectal cancer. Am J Surg 175:198–202

    PubMed  CAS  Google Scholar 

  • Chan GK, Schaar BT, Yen TJ (1998) Characterization of the kinetochore binding domain of CENP-E reveals interactions with the kinetochore proteins CENP-F and hBUBR1. J Cell Biol 143:49–63

    PubMed Central  PubMed  CAS  Google Scholar 

  • Chang TH, Szabo E (2000) Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer. Cancer Res 60:1129–1138

    PubMed  CAS  Google Scholar 

  • Chen YQ, Hsieh JT, Yao F et al. (1999) Induction of apoptosis and G2/M ceH cyde arrest by DCC. Oncogene 18:2747–2754

    PubMed  CAS  Google Scholar 

  • Cho KR, Oliner JD, Simons JWet al. (1994) The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 19:525–531

    PubMed  CAS  Google Scholar 

  • Cunningham JM, Christensen ER, Tester DJ et al. (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455–3460

    PubMed  CAS  Google Scholar 

  • Dix BR, Robbins P, Soong R, Jenner D, House AK, Iacopetta BJ (1994) The common molecular genetic alterations in Dukes’ Band C colorectal carcinomas are not short-term prognostic indicators of survival. Int J Cancer 59:747–751

    PubMed  CAS  Google Scholar 

  • Dong SM, Kim KM, Kim SY et al. (1998) Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res 58:3787–3790

    PubMed  CAS  Google Scholar 

  • Dube S, Heyen F, Jenieck M (1997) Adjuvant chemotherapy in colorectal carcinoma: results of a meta-analysis.Dis Colon Rectum 40:35–41

    PubMed  CAS  Google Scholar 

  • Duval A, Gayet J, Zhou X.P., Iacopetta B, Thomas G, Hamelin R (1999) Frequent frameshift mutations of the TCF-4 gene in colorectal cancers with microsatellite instability. Cancer Res 59:4213–4215

    PubMed  CAS  Google Scholar 

  • Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN (1994) Up-regulation of cydooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188

    PubMed  CAS  Google Scholar 

  • Elsaleh H, Powell B, Soontrapornchai P et al. (2000) p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact on survival of 388 patients with Dukes’ C colon carcinoma. Oncology 58:52–59

    PubMed  CAS  Google Scholar 

  • Eppert K, Scherer SW, Ozcelik H et al. (1996) MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86:543–552

    PubMed  CAS  Google Scholar 

  • Esteller M, Avizienyte E, Corn PG et al. (2000) Epigenetic inactivation of LKB1 in primary tumors associated with the Peutz-Jeghers syndrome. Oncogene 19:164–168

    PubMed  CAS  Google Scholar 

  • Fante R, Di Gregorio C, Losi L, Roncucci L, Ponz DL (1996) Clinico-pathological correlation and prognostic significance of nudear p53 protein in colorectal cancer. Colorectal Cancer Study Group of the University and Health Care District of Modena. Ital J Gastroenterol Hepatol 28:205–210

    CAS  Google Scholar 

  • Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759–767

    PubMed  CAS  Google Scholar 

  • Fearon ER, Cho KR, Nigro JM et al. (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247:49–56

    PubMed  CAS  Google Scholar 

  • Finkelstein SD, Sayegh R, Bakker A, Swalsky P (1993) Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Arch Surg 128:526–531

    PubMed  CAS  Google Scholar 

  • Fuchs CS, Giovannucci EL., Colditz GA, Hunter DJ, Speizer F.E., Willett WC (1994) A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331:1669–1674

    PubMed  CAS  Google Scholar 

  • Ganten D, Ruckpaul K (Hrsg) (2001) Molekularmedizinische Grundlagen von hereditären Tumorerkrankungen.Springer, Berlin Heidelberg New York

    Google Scholar 

  • Giardiello FM, Hamilton SR, Krush AJ et al. (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313–1316

    PubMed  CAS  Google Scholar 

  • Giatromanolaki A, Stathopoulos GP, Tsiobanou E et al. (1999) Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma. Cancer 86:1421–1430

    PubMed  CAS  Google Scholar 

  • Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC (1995) Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87:265–273

    PubMed  CAS  Google Scholar 

  • Graeven U, Schmiegel W (2000) Das Kolonkarzinom. Konsensus der therapeutischen Strategien. Internist (Berl) 41:876–885

    CAS  Google Scholar 

  • Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW (1994) Identification of occult micrometastases in pericolic lymph nodes of Duke’s B colorectal cancer patients using monodonal antibodies against cytokeratin and CC49.Correlation with long-term survival. Cancer 73:563–569

    PubMed  CAS  Google Scholar 

  • Gruber SB, Entius MM, Petersen GM et al. (1998) Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res 58:5267–5270

    PubMed  CAS  Google Scholar 

  • Gryfe R, Kim H, Hsieh ET et al. (2000) Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 342:69–77

    PubMed  CAS  Google Scholar 

  • Guan RJ, Ford H.L., Fu Y, Li Y, Shaw LM, Pardee AB (2000) Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res 60:749–755

    PubMed  CAS  Google Scholar 

  • Hahn SA, Schutte M, Hoque AT et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271:350–353

    PubMed  CAS  Google Scholar 

  • Hamelin R, Laurent-Puig P, Olschwang S et al. (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 106:42–48

    PubMed  CAS  Google Scholar 

  • Harris JE, Ryan L, Hoover HC et al. (2000) Adjuvant active specific immunotherapy for stage 11 and III colon cancer with an autologous tumor cell vaccine: Eastern Cooperative Oncology Group Study E5283. J Clin Oncol 18:148–157

    PubMed  CAS  Google Scholar 

  • He TC, Chan TA, Vogelstein B, Kinzier KW (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335–345

    PubMed Central  PubMed  CAS  Google Scholar 

  • Heald RJ, Moran BJ, Ryall RD, Sexton R., MacFariane JK (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg 133:894–899

    Google Scholar 

  • Hedrick L, Cho KR, Boyd J, Risinger J, Vogelstein B (1992) DCC: a tumor suppressor gene expressed on the cell surface. Cold Spring Harb Symp Quant Biol 57:345–351

    PubMed  CAS  Google Scholar 

  • Heiss MM, Babie R, Allgayer H et al. (1995) Tumor-associated proteolysis and prognosis: new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. J Clin Oncol 13:2084–2093

    PubMed  CAS  Google Scholar 

  • Hemminki A, Markie D, Tomlinson I et al. (1998) A serine/threonine kinase gene defective in Peutz-Jeghers syndrome.Nature 391:184–187

    PubMed  CAS  Google Scholar 

  • Hermanek P, Wiebelt H, Riedl S, Staimmer D, Hermanek P, Studiengruppe Kolorektales Karzinom (SGKRK) (1994) Langzeitergebnisse der chirurgischen Therapic des Coloncareinoms. Chirurg 65:287–297

    PubMed  Google Scholar 

  • Hermanek P, Wiebelt H, Staimmer D, Riedl S (1995) Prognostic factors of rectum carcinoma-experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 81:60–64

    PubMed  CAS  Google Scholar 

  • Hohenberger W, Hermanek P, König HJ (2000) Kolon-, Rektum-und Analkanaltumoren. In: Hahn WG, Riemann JF, Demling L (Hrsg) Klinische Gastroenterologie, 3. Aufl. Thieme, Stuttgart New York, S 991–1024

    Google Scholar 

  • Houlston R, Bevan S, Williams A et al. (1998) Mutations in DPC4 (SMAD4) cause juvenile polyposis syndrome, but only account for a minority of cases. Hum Mol Genet7:1907–1912

    PubMed  CAS  Google Scholar 

  • Howe JR, Ringold JC, Summers RW, Mitros FA, Nishimura D.Y., Stone EM (1998) A gene for familial juvenile polyposis maps to chromosome 18q21.1. Am J Hum Genet 62:1129–1136

    PubMed Central  PubMed  CAS  Google Scholar 

  • Huang J, Papadopoulos N, McKinley AJ et al. (1996) APC mutations in colorectal tumors with mismatch repair deficiency. Proc Natl Acad Sci USA 93:9049–9054

    PubMed Central  PubMed  CAS  Google Scholar 

  • Imai Y, Shiratori Y, Kato N, Inoue T, Omata M (1999) Mutational inactivation of mitotic checkpoint genes, hsMAD2 and hBUB1, is rare in sporadic digestive tract cancers. Jpn J Cancer Res 90:837–840

    PubMed  CAS  Google Scholar 

  • Isaka N, Nozue M, Doy M, Fukao K (1999) Prognostic significance of perirectal lymph node micrometastases in Dukes’ B rectal carcinoma: an immunohistochemical study by CAM5.2. Clin Cancer Res 5:2065–2068

    PubMed  CAS  Google Scholar 

  • Itoh F, Hinoda Y, Ohe M et al. (1993) Decreased expression of DCC mRNA in human colorectal cancers. Int J Cancer 53:260–263

    PubMed  CAS  Google Scholar 

  • Jass JR, Sobin LH (1989) Histological typing of intestinal tumours.WHO International Histological Classification of Tumours, 2nd edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Jen J, Kim H, Piantadosi S et al. (1994a) Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 331:213–221

    PubMed  CAS  Google Scholar 

  • Jen J, Powell SM, Papadopoulos N et al. (1994b) Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54:5523–5526

    PubMed  CAS  Google Scholar 

  • Jenne DE, Reimann H, Nezu J et al. (1998) Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38–43

    PubMed  CAS  Google Scholar 

  • Kane MF, Loda M, Gaida GM et al. (1997) Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor celllines. Cancer Res 57:808–811

    PubMed  CAS  Google Scholar 

  • Kataoka M, Okabayashi T, Orita K (1995) Decreased expression of DCC mRNA in gastric and colorectal cancer. Surg Today 25:1001–1007

    PubMed  CAS  Google Scholar 

  • Kato M, Ho Y, Kobayashi S, Isono K (1996) Detection of DCC and Ki-ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence.Cancer 77:1729–1735

    PubMed  CAS  Google Scholar 

  • Keino-Masu K, Masu M, Hinck L et al. (1996) Deleted in colorectal cancer (DCC) encodes a netrin receptor. Cell 87:175–185

    PubMed  CAS  Google Scholar 

  • Kern SE, Fearon ER, Tersmette KWet al. (1989) Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 261:3099–3103

    PubMed  CAS  Google Scholar 

  • Khine K, Smith DR, Goh HS (1994) High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer. Cancer 73:28–35

    PubMed  CAS  Google Scholar 

  • Kinzler KW, Vogelstein B (1996) Lessons from hereditary colorectal cancer. Cell 87:159–170

    PubMed  CAS  Google Scholar 

  • Kinzler KW, Nilbert MC, Su LK et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science 253:661–665

    PubMed  CAS  Google Scholar 

  • Klingelhutz AJ, Hedrick L, Cho KR, McDougall JK (1995) The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene 10:1581–1586

    PubMed  CAS  Google Scholar 

  • Knudson AGJ, Meadows AT, Nichols WW, Hili R. (1976) Chromosomal deletion and retinoblastoma. N Engl J Med 295:1120–1123

    PubMed  Google Scholar 

  • Konishi M, Kikuchi-Yanoshita R, Tanaka K et al. (1996) Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenterology 111:307–317

    PubMed  CAS  Google Scholar 

  • Korchynskyi O, Landstrom M, Stoika R et al. (1999) Expression of Smad proteins in human colorectal cancer. Int J Cancer 82:197–202

    PubMed  CAS  Google Scholar 

  • Koyama M, Ito M, Nagai H, Emi M, Moriyama Y (1999) Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Mutat Res 406:71–77

    PubMed  CAS  Google Scholar 

  • Kune GA, Kune S, Vitetta L, Watson LF (1992) Smoking and colorectal cancer risk: data from the Melbourne Colorectal Cancer Study and brief review of literature. Int J Cancer 50:369–372

    PubMed  CAS  Google Scholar 

  • Labayle D, Fischer D, Vielh P et al. (1991) Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 101:635–639

    PubMed  CAS  Google Scholar 

  • Laird PW, Jaenisch R (1994) DNA methylation and cancer. Hum Mol Genet 3:1487–1495

    PubMed  CAS  Google Scholar 

  • Lanza G, Matteuzzi M, Gafa R et al. (1998) Chromosome 18q allelic loss and prognosis in stage II and III colon cancer. Int J Cancer 79:390–395

    PubMed  CAS  Google Scholar 

  • Launonen V, Avizienyte E, Loukola A et al. (2000) No evidence of Peutz-Jeghers syndrome gene LKB1 involvement in leftsided colorectal carcinomas. Cancer Res 60:546–548

    PubMed  CAS  Google Scholar 

  • Laurent-Puig P, Olschwang S, Delattre O et al. (1992) Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 102:1136–1141

    PubMed  CAS  Google Scholar 

  • Lee JC, Wang ST, Lai MD, Lin YJ, Yang HB (1996) K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers. Anticancer Res 16:3839–3844

    PubMed  CAS  Google Scholar 

  • Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643–649

    PubMed  CAS  Google Scholar 

  • Lev Z, Kislitsin D, Rennert G, Lerner A (2000) Utilization of K-ras mutations identified in stool DNA for the early detection of colorectal cancer. J Cell Bioehern [Suppl]34:35–39

    CAS  Google Scholar 

  • Lichtenstein P, Holm NY, Verkasalo PK et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85

    PubMed  CAS  Google Scholar 

  • Liefers GJ, Cleton-Jansen AM, van de Velde CJ et al. (1998) Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339:223–228

    PubMed  CAS  Google Scholar 

  • Lindemann F, Schlimok G, Dirschedl P, Witte J, Riethmüller G (1992) Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients. Lancet 340:685–689

    PubMed  CAS  Google Scholar 

  • Livesey FJ (1999) Netrins and netrin receptors. Cell Mol Life Sci 56:62–68

    PubMed  CAS  Google Scholar 

  • Lothe RA, Peltomäki P, Meling GI et al. (1993) Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53:5849–5852

    PubMed  CAS  Google Scholar 

  • Lu SL, Kawabata M, Imamura T et al. (1998) HNPCC associated with germline mutation in the TGF-beta type II receptor gene. Nat Genet 19:17–18

    PubMed  CAS  Google Scholar 

  • MacGrogan D, Pegram M, Slamon D, Bookstein R (1997) Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 15:1111–1114

    PubMed  CAS  Google Scholar 

  • Maitra A, Molberg K, Albores-Saavedra J, Lindberg G (2000) Loss of Dpc4 expression in colonie adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol 157:1105–1111

    PubMed Central  PubMed  CAS  Google Scholar 

  • Markowitz S, Wang J, Myeroff L et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336–1338

    PubMed  CAS  Google Scholar 

  • Martinez-Lopez E, Abad A, Font A et al. (1998) Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. Gastroenterology 114:1180–1187

    PubMed  CAS  Google Scholar 

  • Mehlen P, Rabizadeh S, Snipas SJ, Assa-Munt N, Salvesen GS, Bredesen DE (1998) The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395:801–804

    PubMed  CAS  Google Scholar 

  • Minamoto T, Mai M, Ronai Z (2000) K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers-a review. Cancer Detect Prev 24:1–12

    PubMed  CAS  Google Scholar 

  • Mirabelli-Primdahl L, Gryfe R, Kim H et al. (1999) Beta-catenin mutations are specific for colorectal carcinomas with microsatellite instability but occur in endometrial carcinomas irrespective of mutator pathway. Cancer Res 59:3346–3351

    PubMed  CAS  Google Scholar 

  • Miyaki M, Konishi M, Kikuchi-Yanoshita R et al. (1994) Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 54:3011–3020

    PubMed  CAS  Google Scholar 

  • Miyaki M, Iijima T, Kimura J et al. (1999a) Frequent mutation of beta-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res 59:4506–4509

    PubMed  CAS  Google Scholar 

  • Miyaki M, Iijima T, Konishi M et al. (1999b) Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene 18:3098–3103

    PubMed  CAS  Google Scholar 

  • Miyoshi Y, Nagase H, Ando H et al. (1992) Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1:229–233

    PubMed  CAS  Google Scholar 

  • Mulcahy HE, Skelly MM, Husain A, O’Donoghue DP (1996) Long-term outcome following curative surgery for malignant large bowel obstruction. Br J Surg 83:46–50

    PubMed  CAS  Google Scholar 

  • Narayanan R, Lawlor KG, Schaapveld RQ et al. (1992) Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene 7:553–561

    PubMed  CAS  Google Scholar 

  • Nemunaitis J, Cox J, Meyer W, Courtney A, Mues G (1997) Irinotecan hydrochloride (CPT-11) resistance identified by K-ras mutation in patients with progressive colon cancer after treatment with 5-fluorouracil (5-FU). Am J Clin Oncol 20:527–529

    PubMed  CAS  Google Scholar 

  • Newland RC, Dent OF, Lyttle MN, Chapuis PH, Bokey EL. (1994) Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 73:2076–2082

    PubMed  CAS  Google Scholar 

  • Nollau P, Moser C, Weinland G, Wagener C (1996) Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 66:332–336

    PubMed  CAS  Google Scholar 

  • Nordlinger B, Guiguet M, Vaillant JC et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.Cancer 77:1254–1262

    PubMed  CAS  Google Scholar 

  • Nowell PC (1976) The clonal evolution of tumor cell populations.Science 194:23–28

    PubMed  CAS  Google Scholar 

  • Nucci MR, Robinson CR, Longo P, Campbell P, Hamilton SR (1997) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 28:1396–1407

    PubMed  CAS  Google Scholar 

  • Ogunbiyi OA, Goodfellow PJ, Herfarth K et al. (1998) Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427–433

    PubMed  CAS  Google Scholar 

  • Olschwang S, Hamelin R, Laurent-Puig P et al. (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94:12122–12127

    PubMed Central  PubMed  CAS  Google Scholar 

  • Pantel K, Knebel D von (2000) Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol 12:95–101

    PubMed  CAS  Google Scholar 

  • Paradiso A, Simone G, Petroni S et al. (2000) Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560–567

    PubMed Central  PubMed  CAS  Google Scholar 

  • Parsons R, Myeroff LL, Liu B et al. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550

    PubMed  CAS  Google Scholar 

  • Pocard M, Bras-Goncalves R, Hamelin R, Northover J, Poupon MF (2000) Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res20:85–90

    PubMed  CAS  Google Scholar 

  • Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332:FI27–FI47

    Google Scholar 

  • Poller DN, Baxter KJ, Shepherd NA (1997) p53 and Rbl protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 75:87–93

    PubMed Central  PubMed  CAS  Google Scholar 

  • Porter GA, Soskolne CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167

    PubMed Central  PubMed  CAS  Google Scholar 

  • Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916–932

    PubMed  CAS  Google Scholar 

  • Powell SM, Zilz N, Beazer-Barday Y et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235–237

    PubMed  CAS  Google Scholar 

  • Pricolo VE, Finkelstein SD, Wu TT et al. (1996) Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg 171:41–46

    PubMed  CAS  Google Scholar 

  • Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI (1997) Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132:371–374

    PubMed  CAS  Google Scholar 

  • Resta N, Simone C, Mareni C et al. (1998) STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res 58:4799–4801

    PubMed  CAS  Google Scholar 

  • Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer.Dis Colon Rectum 41:755–760

    PubMed  CAS  Google Scholar 

  • Ried T, Heselmeyer-Haddad K, Biegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195–204

    PubMed  CAS  Google Scholar 

  • Nollau P, Moser C, Weinland G, Wagener C (1996) Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 66:332–336

    PubMed  CAS  Google Scholar 

  • Nordlinger B, Guiguet M, Vaillant JC et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.Cancer 77:1254–1262

    PubMed  CAS  Google Scholar 

  • Nowell PC (1976) The clonal evolution of tumor cell populations.Science 194:23–28

    PubMed  CAS  Google Scholar 

  • Nucci MR, Robinson CR, Longo P, Campbell P, Hamilton SR (1997) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 28:1396–1407

    PubMed  CAS  Google Scholar 

  • Ogunbiyi OA, Goodfellow PJ, Herfarth K et al. (1998) Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427–433

    PubMed  CAS  Google Scholar 

  • Olschwang S, Hamelin R, Laurent-Puig P et al. (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94:12122–12127

    PubMed Central  PubMed  CAS  Google Scholar 

  • Pantel K, Knebel D von (2000) Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol 12:95–101

    PubMed  CAS  Google Scholar 

  • Paradiso A, Simone G, Petroni S et al. (2000) Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560–567

    PubMed Central  PubMed  CAS  Google Scholar 

  • Parsons R, Myeroff LL, Liu B et al. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550

    PubMed  CAS  Google Scholar 

  • Pocard M, Bras-Goncalves R, Hamelin R, Northover J, Poupon MF (2000) Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res20:85–90

    PubMed  CAS  Google Scholar 

  • Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332:FI27–FI47

    Google Scholar 

  • Poller DN, Baxter KJ, Shepherd N.A (1997) p53 and Rbl protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 75:87–93

    PubMed Central  PubMed  CAS  Google Scholar 

  • Porter GA, Soskolne CL, Yakimets WW, Newman SC (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167

    PubMed Central  PubMed  CAS  Google Scholar 

  • Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916–932

    PubMed  CAS  Google Scholar 

  • Powell SM, Zilz N, Beazer-Barday Y et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235–237

    PubMed  CAS  Google Scholar 

  • Pricolo VE, Finkelstein SD, Wu TT et al. (1996) Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg 171:41–46

    PubMed  CAS  Google Scholar 

  • Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI (1997) Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132:371–374

    PubMed  CAS  Google Scholar 

  • Resta N, Simone C, Mareni C et al. (1998) STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res 58:4799–4801

    PubMed  CAS  Google Scholar 

  • Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer.Dis Colon Rectum 41:755–760

    PubMed  CAS  Google Scholar 

  • Ried T, Heselmeyer-Haddad K, Biegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195–204

    PubMed  CAS  Google Scholar 

  • Nollau P, Moser C, Weinland G, Wagener C (1996) Detection of K-ras mutations in stools of patients with colorectal cancer by mutant-enriched PCR. Int J Cancer 66:332–336

    PubMed  CAS  Google Scholar 

  • Nordlinger B, Guiguet M, Vaillant JC et al. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie.Cancer 77:1254–1262

    PubMed  CAS  Google Scholar 

  • Nowell PC (1976) The clonal evolution of tumor cell populations. Science 194:23–28

    PubMed  CAS  Google Scholar 

  • Nucci MR, Robinson CR, Longo P, Campbell P, Hamilton SR (1997) Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol 28:1396–1407

    PubMed  CAS  Google Scholar 

  • Ogunbiyi OA, Goodfellow PJ, Herfarth K et al. (1998) Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol 16:427–433

    PubMed  CAS  Google Scholar 

  • Olschwang S, Hamelin R, Laurent-Puig P et al. (1997) Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 94:12122–12127

    PubMed Central  PubMed  CAS  Google Scholar 

  • Pantel K, Knebel D von (2000) Detection and clinical relevance of micrometastatic cancer cells. Curr Opin Oncol 12:95–101

    PubMed  CAS  Google Scholar 

  • Paradiso A, Simone G, Petroni S et al. (2000) Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients. Br J Cancer 82:560–567

    PubMed Central  PubMed  CAS  Google Scholar 

  • Parsons R, Myeroff LL, Liu B et al. (1995) Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 55:5548–5550

    PubMed  CAS  Google Scholar 

  • Pocard M, Bras-Goncalves R, Hamelin R, Northover J, Poupon MF (2000) Response to 5-fluorouracil of orthotopically xenografted human colon cancers with a microsatellite instability: influence of P53 status. Anticancer Res20:85–90

    PubMed  CAS  Google Scholar 

  • Polakis P (1997) The adenomatous polyposis coli (APC) tumor suppressor. Biochim Biophys Acta 1332:FI27–FI47

    Google Scholar 

  • Poller DN, Baxter KJ, Shepherd N.A (1997) p53 and Rbl protein expression: are they prognostically useful in colorectal cancer? Br J Cancer 75:87–93

    PubMed Central  PubMed  CAS  Google Scholar 

  • Porter GA, Soskolne CL, Yakimets WW, Newman.S.C (1998) Surgeon-related factors and outcome in rectal cancer. Ann Surg 227:157–167

    PubMed Central  PubMed  CAS  Google Scholar 

  • Potter JD (1999) Colorectal cancer: molecules and populations. J Natl Cancer Inst 91:916–932

    PubMed  CAS  Google Scholar 

  • Powell SM, Zilz N, Beazer-Barday Y et al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235–237

    PubMed  CAS  Google Scholar 

  • Pricolo VE, Finkelstein SD, Wu TT et al. (1996) Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon. Am J Surg 171:41–46

    PubMed  CAS  Google Scholar 

  • Pricolo VE, Finkelstein SD, Hansen K, Cole BF, Bland KI (1997) Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg 132:371–374

    PubMed  CAS  Google Scholar 

  • Resta N, Simone C, Mareni C et al. (1998) STK11 mutations in Peutz-Jeghers syndrome and sporadic colon cancer. Cancer Res 58:4799–4801

    PubMed  CAS  Google Scholar 

  • Reymond MA, Dworak O, Remke S, Hohenberger W, Kirchner T, Kockerling F (1998) DCC protein as a predictor of distant metastases after curative surgery for rectal cancer.Dis Colon Rectum 41:755–760

    PubMed  CAS  Google Scholar 

  • Ried T, Heselmeyer-Haddad K, Biegen H, Schrock E, Auer G (1999) Genomic changes defining the genesis, progression, and malignancy potential in solid human tumors: a phenotype/genotype correlation. Genes Chromosomes Cancer 25:195–204

    PubMed  CAS  Google Scholar 

  • Riethmüller G, Holz E, Schlimok G et al. (1998) Monoclonal antibody therapy for resected Dukes’ C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 16:1788–1794

    PubMed  Google Scholar 

  • Riggins GJ, Kinzier KW, Vogelstein B, Thiagalingam S (1997) Frequency of Smad gene mutations in human cancers. Cancer Res 57:2578–2580

    PubMed  CAS  Google Scholar 

  • Roberts BT, Farr KA, Hoyt MA (1994) The Saccharomyces cerevisiae checkpoint gene BUB1 encodes a novel protein kinase. Mol Cell Biol 14:8282–8291

    PubMed Central  PubMed  CAS  Google Scholar 

  • Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P (1996) Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023–1026

    PubMed  CAS  Google Scholar 

  • Saito M, Yamaguchi A, Goi T et al. (1999) Expression of DCC protein in colorectal tumors and its relationship to tumor progression and metastasis. Oncology 56:134–141

    PubMed  CAS  Google Scholar 

  • Sarraf P, Mueller E, Jones D et al. (1998) Differentiation and reversal of malignant changes in colon cancer through PPARgamma. Nat Med 4:1046–1052

    PubMed  CAS  Google Scholar 

  • Sarraf P, Mueller E, Smith WM et al. (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell 3:799–804

    PubMed  CAS  Google Scholar 

  • Schmiegel W, Adler G, Frühmorgen P et al. (2000) Kolorektales Karzinom: Prävention und Früherkennung in der asymptomatischen Bevölkerung-Vorsorge bei Risikopatienten-Endoskopische Diagnostik, Therapic und Nachsorge von Polypen und Karzinomen. Z Gastroenterol 38:49–75

    PubMed  CAS  Google Scholar 

  • Schumpelick V, Willis S, Kasperk R (2000) Moderne Operationsverfahren des Rektumkarzinoms: Sind adjuvante Maßnahmen notwendig? Dtsch Arztebl 97:A1138

    Google Scholar 

  • Schwarte-Waldhoff I, Klein S, Blass-Kampmann S et al. (1999) DPC4/SMAD4 mediated tumor suppression of colon carcinoma cells is associated with reduced urokinase expression. Oncogene 18:3152–3158

    PubMed  CAS  Google Scholar 

  • Schwarte-Waldhoff I, Volpert OV, Bouck NP et al. (2000) Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis. Proc Natl Acad Sci USA 97:9624–9629

    PubMed Central  PubMed  CAS  Google Scholar 

  • Shibata D, Reale MA, Lavin P et al. (1996) The DCC protein and prognosis in colorectal cancer. N Engl J Med 335:1727–1732

    PubMed  CAS  Google Scholar 

  • Shiff SJ, Rigas B (1997) Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology 113:1992–1998

    PubMed  CAS  Google Scholar 

  • Shitoh K, Furukawa T, Kojima M et al. (2001) Frequent activation of the beta-catenin-Tcf signaling pathway in nonfamilial colorectal careinomas with microsatellite instability. Genes Chromosomes Cancer 30:32–37

    PubMed  CAS  Google Scholar 

  • Sidransky D, Tokino T, Hamilton SR et al. (1992) Identification of ras on co gene mutations in the stool of patients with curable colorectal tumors. Science 256:102–105

    PubMed  CAS  Google Scholar 

  • Smith AJ, Stern HS, Penner M et al. (1994) Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons. Cancer Res 54:5527–5530

    PubMed  CAS  Google Scholar 

  • Smith DR, Ji C.Y., Goh HS (1996) Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 74:216–223

    PubMed Central  PubMed  CAS  Google Scholar 

  • Smith-Ravin J, England J, Talbot IC, Bodmer W (1995) Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients. Gut 36:81–86

    PubMed Central  PubMed  CAS  Google Scholar 

  • Soussi T (2000) p53 antibodies in the sera of patients with various types of cancer: a review. Cancer Res 60:1777–1788

    PubMed  CAS  Google Scholar 

  • Sparks AB, Morin PJ, Vogelstein B, Kinzier KW (1998) Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130–1134

    PubMed  CAS  Google Scholar 

  • Starzynska T, Bromley M, Marlicz K, Roberts SA, Ucinski M, Stern PL (1997) Accumulation of p53 in relation to longterm prognosis in colorectal carcinoma. Eur J Gastroenterol Hepatol 9:183–186

    PubMed  CAS  Google Scholar 

  • Steinbach G, Lynch PM, Phillips RK et al. (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342:1946–1952

    PubMed  CAS  Google Scholar 

  • Takagi Y, Kohmura H, Futamura M et al. (1996) Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 111:1369–1372

    PubMed  CAS  Google Scholar 

  • Takagi Y, Koumura H, Futamura M et al. (1998) Somatic alterations of the SMAD-2 gene in human colorectal cancers. Br J Cancer 78:1152–1155

    PubMed Central  PubMed  CAS  Google Scholar 

  • Takahashi Y, Tucker SL, Kitadai Y et al. (1997) Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg 132:541–546

    PubMed  CAS  Google Scholar 

  • Takaku K, Oshima M, Miyoshi H, Matsui M, Seldin MF, Taketo MM (1998) Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92:645–656

    PubMed  CAS  Google Scholar 

  • Takanishi D.MJ, Angriman I, Yaremko ML, Montag A, Westbrook CA, Michelassi F (1995) Chromosome 17p allelic loss in colorectal carcinoma. Clinical significance. Arch Surg 130:585–588

    PubMed  Google Scholar 

  • Takenoshita S, Tani M, Mogi A et al. (1998) Mutation analysis of the Smad2 gene in human colon cancers using genomic DNA and intron primers. Carcinogenesis 19:803–807

    PubMed  CAS  Google Scholar 

  • Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 90:1529–1536

    PubMed  CAS  Google Scholar 

  • Tanaka K, Oshimura M, Kikuchi R, Seki M, Hayashi T, Miyaki M (1991) Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature 349:340–342

    PubMed  CAS  Google Scholar 

  • Taylor SS, McKeon F (1997) Kinetochore localization of murine Bub1 is required for normal mitotic timing and checkpoint response to spindle damage. Cell 89:727–735

    PubMed  CAS  Google Scholar 

  • Taylor SS, Ha E, McKeon F (1998) The human homologue of Bub3 is required for kinetochore localization of Bub1 and a Mad3/Bub1-related protein kinase. J Cell Biol 142:1–11

    PubMed Central  PubMed  CAS  Google Scholar 

  • Thiagalingam S, Lengauer C, Leach FS et al. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13:343–346

    PubMed  CAS  Google Scholar 

  • Thibodeau SN, French AJ, Cunningham J.M et al. (1998) Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. Cancer Res 58:1713–1718

    PubMed  CAS  Google Scholar 

  • Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C (1998) A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 317:559–565

    PubMed Central  PubMed  CAS  Google Scholar 

  • Trojan J, Brieger A, Raedle J, Esteller M, Zeuzem S (2000) 5’-CpG island methylation of the LKB1/STK11 promoter and allelic loss at chromosome 19p13.3 in sporadic colorectal cancer. Gut 47:272–276

    PubMed Central  PubMed  CAS  Google Scholar 

  • Troungos C, Valavanis C, Kapranos N, Kittas C (1997) K-ras mutation in Greek patients with poorly and moderately differentiated tumours of the lower intestinal tract. Anticancer Res 17:1399–1404

    PubMed  CAS  Google Scholar 

  • Van Beizen N, Dinjens W.N., Diesveld MP et al. (1997) A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab Invest 77:85–92

    Google Scholar 

  • Veigl ML, Kasturi L, Olechnowicz J et al. (1998) Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Natl Acad Sci USA 95:8698-8702

    Google Scholar 

  • Vermorken JB, Claessen AM, Tinteren H van et al. (1999) Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial. Lancet 353:345–350

    PubMed  CAS  Google Scholar 

  • Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525–532

    PubMed  CAS  Google Scholar 

  • Winawer SJ, Zauber AG, Gerdes H et al. (1996) Risk of colorectal cancer in the families of patients with adenomatous polyps.National Polyp Study Workgroup. N Engl J Med 334:82–87

    PubMed  CAS  Google Scholar 

  • Wittekind C, Wagner C (1997) TNM-Klassifikation maligner Tumoren, 5. Aufl. Springer, Berlin Heidelberg New York

    Google Scholar 

  • World Cancer Research Fund (1996) Food, nutrition and the prevention of cancer: a global perspective. American Institute for Cancer Research, Washington, DC

    Google Scholar 

  • Wu GD (2000) A nuclear receptor to prevent colon cancer. N Engl J Med 342:651–653

    PubMed  CAS  Google Scholar 

  • Zeng Z.S., Sarkis AS, Zhang ZF et al. (1994) p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 12:2043–2050

    PubMed  CAS  Google Scholar 

  • Zhou S, Buckhaults P, Zawel L et al. (1998a) Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc Natl Acad Sci USA 95:2412–2416

    PubMed Central  PubMed  CAS  Google Scholar 

  • Zhou H, Kuang J, Zhong L et al. (1998b) Tumour amplified kinase STK15/BTAK in duces centrosome amplification, aneuploidy and transformation. Nat Genet 20:189–193

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Karsten Schulmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wolff Schmiegel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Max-Delbrück-Centrum für Molekulare Medizin (MDC), Robert-Rössle-Str.10, 13122, Berlin-Buch, Germany

    Detlev Ganten  & Klaus Ruckpaul  & 

  2. Medizinische Universitätsklinik Knappschaftskrankenhaus, In der Schornau 23-25, 44892, Bochum-Langendreer, Germany

    Stephan A. Hahn  & Wolff Schmiegel  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schulmann, K., Schmiegel, W. (2002). Kolorektales Karzinom. In: Ganten, D., Ruckpaul, K., Hahn, S.A., Schmiegel, W. (eds) Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen. Molekulare Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56297-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56297-6_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62572-5

  • Online ISBN: 978-3-642-56297-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation